Robert Orlowski, Florence Maude Thomas Cancer Research Professor at the University of Texas MD Anderson Cancer Center, shared a post on X:
“Myeloma Paper of the Day: S-MRD<10-5 (sustained MRD two consecutive tests at least 1 year apart) is best PFS predictor and yields best predictive models for risk of MRD resurgence or progression after quad induction + ASCT and fixed duration therapy.”
Authors: Smith Giri, Binod Dhakal, Natalie Callander, Eva Medvedova, Kelly Godby, Bhagirathbhai Dholaria, Susan Bal, Gayathri Ravi, Saurabh Chhabra, Rebecca Silbermann, Luciano Costa.
More posts featuring Robert Orlowski.
